CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-arm, Prospective, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04556071
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:56.725598+00:00
Published At: 2020-11-10T00:00:00+00:00
Record Updated At: 2020-11-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ovarian Neoplasms", "Fallopian Tube Neoplasms", "Endocrine Gland Neoplasms", "Neoplasms by Site", "Neoplasms", "Genital Neoplasms, Female", "Urogenital Neoplasms", "Neoplasms, Glandular and Epithelial", "Neoplasms by Histologic Type", "Carcinoma, Ovarian Epithelial", "Ovarian Diseases", "Adnexal Diseases", "Genital Diseases, Female", "Endocrine System Diseases", "Gonadal Disorders", "Carcinoma", "Bevacizumab", "Enzyme Inhibitors", "Antineoplastic Agents", "Molecular Mechanisms of Pharmacological Action", "Angiogenesis", "BRCA1 Mutation", "BRCA2 Mutation", "Homologous Recombination Deficiency"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2020-11-10"
protocolSection.identificationModule.nctId: "NCT04556071"
protocolSection.identificationModule.officialTitle: "A Single-arm, Prospective, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.